Statistics for SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection (rCDI)

Total visits

views
SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent Clostridioides difficile Infection (rCDI) 12

Total visits per month

views
May 2024 2
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0

File Visits

views
antibiotics-11-01234.pdf 7

Top country views

views
United States 12

Top city views

views
Indianapolis 11
Franklin 1